Our goal is to create the platform for rapid development of personalized nanomedicine drug delivery systems. We intend to do it by developing the intellectual property of EVO-NANO results in accordance to market and regulatory demands.
Origins
We build upon the computational platform that is under development in H2020 FET-Open project EVO-NANO. The platform uses AI to generate and in silico test novel cancer treatments.